AZN logo

AstraZeneca (AZN) Income tax

annual income tax:

$1.65B+$712.00M(+75.91%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AZN annual income tax is $1.65 billion, with the most recent change of +$712.00 million (+75.91%) on December 31, 2024.
  • During the last 3 years, AZN annual income tax has risen by +$2.03 billion (+534.21%).
  • AZN annual income tax is now -49.43% below its all-time high of $3.26 billion, reached on December 31, 2009.

Performance

AZN Income tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

quarterly income tax:

$481.00M+$315.00M(+189.76%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AZN quarterly income tax is $481.00 million, with the most recent change of +$315.00 million (+189.76%) on March 31, 2025.
  • Over the past year, AZN quarterly income tax has dropped by -$139.00 million (-22.42%).
  • AZN quarterly income tax is now -47.20% below its all-time high of $911.00 million, reached on September 30, 2009.

Performance

AZN quarterly income tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

TTM income tax:

$1.51B-$139.00M(-8.42%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AZN TTM income tax is $1.51 billion, with the most recent change of -$139.00 million (-8.42%) on March 31, 2025.
  • Over the past year, AZN TTM income tax has increased by +$411.00 million (+37.36%).
  • AZN TTM income tax is now -53.69% below its all-time high of $3.26 billion, reached on December 31, 2009.

Performance

AZN TTM income tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

Income tax Formula

Income Tax Expense = Current Tax Expense + Deferred Tax Expense

AZN Income tax Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+75.9%-22.4%+37.4%
3 y3 years+534.2%+191.5%+678.9%
5 y5 years+414.0%+160.0%+385.9%

AZN Income tax Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+308.3%-22.4%+166.8%-8.4%+257.7%
5 y5-yearat high+308.3%-22.4%+166.8%-8.4%+257.7%
alltimeall time-49.4%+308.3%-47.2%+156.3%-53.7%+257.7%

AZN Income tax History

DateAnnualQuarterlyTTM
Mar 2025
-
$481.00M(+189.8%)
$1.51B(-8.4%)
Dec 2024
$1.65B(+75.9%)
$166.00M(-58.0%)
$1.65B(+16.0%)
Sep 2024
-
$395.00M(-15.8%)
$1.42B(+9.3%)
Jun 2024
-
$469.00M(-24.4%)
$1.30B(+18.3%)
Mar 2024
-
$620.00M(-1100.0%)
$1.10B(+17.3%)
Dec 2023
$938.00M(-218.4%)
-$62.00M(-122.6%)
$938.00M(+7.1%)
Sep 2023
-
$274.00M(+2.2%)
$876.00M(-842.4%)
Jun 2023
-
$268.00M(-41.5%)
-$118.00M(-76.4%)
Mar 2023
-
$458.00M(-469.4%)
-$499.00M(-37.0%)
Dec 2022
-$792.00M(+108.4%)
-$124.00M(-82.8%)
-$792.00M(-17.3%)
Sep 2022
-
-$720.00M(+537.2%)
-$958.00M(+62.9%)
Jun 2022
-
-$113.00M(-168.5%)
-$588.00M(+125.3%)
Mar 2022
-
$165.00M(-156.9%)
-$261.00M(-31.3%)
Dec 2021
-$380.00M(-149.2%)
-$290.00M(-17.1%)
-$380.00M(-627.8%)
Sep 2021
-
-$350.00M(-263.6%)
$72.00M(-88.5%)
Jun 2021
-
$214.00M(+365.2%)
$624.00M(-1.4%)
Mar 2021
-
$46.00M(-71.6%)
$633.00M(-18.0%)
Dec 2020
$772.00M(+140.5%)
$162.00M(-19.8%)
$772.00M(+34.7%)
Sep 2020
-
$202.00M(-9.4%)
$573.00M(+14.6%)
Jun 2020
-
$223.00M(+20.5%)
$500.00M(+60.8%)
Mar 2020
-
$185.00M(-600.0%)
$311.00M(-3.1%)
Dec 2019
$321.00M(-663.2%)
-$37.00M(-128.7%)
$321.00M(+306.3%)
Sep 2019
-
$129.00M(+279.4%)
$79.00M(+276.2%)
Jun 2019
-
$34.00M(-82.6%)
$21.00M(-73.8%)
Mar 2019
-
$195.00M(-169.9%)
$80.00M(-240.4%)
Dec 2018
-$57.00M(-91.1%)
-$279.00M(-493.0%)
-$57.00M(-91.0%)
Sep 2018
-
$71.00M(-23.7%)
-$632.00M(+4.3%)
Jun 2018
-
$93.00M(+60.3%)
-$606.00M(-7.2%)
Mar 2018
-
$58.00M(-106.8%)
-$653.00M(+1.9%)
Dec 2017
-$641.00M(-539.0%)
-$854.00M(-980.4%)
-$641.00M(-210.7%)
Sep 2017
-
$97.00M(+110.9%)
$579.00M(+255.2%)
Jun 2017
-
$46.00M(-34.3%)
$163.00M(+38.1%)
Mar 2017
-
$70.00M(-80.9%)
$118.00M(-19.2%)
Dec 2016
$146.00M(-39.9%)
$366.00M(-214.7%)
$146.00M(-164.6%)
Sep 2016
-
-$319.00M(<-9900.0%)
-$226.00M(-189.0%)
Jun 2016
-
$1.00M(-99.0%)
$254.00M(+18.1%)
Mar 2016
-
$98.00M(-1733.3%)
$215.00M(-11.5%)
Dec 2015
$243.00M(+2109.1%)
-$6.00M(-103.7%)
$243.00M(-2530.0%)
Sep 2015
-
$161.00M(-523.7%)
-$10.00M(-90.2%)
Jun 2015
-
-$38.00M(-130.2%)
-$102.00M(-2140.0%)
Mar 2015
-
$126.00M(-148.6%)
$5.00M(-54.5%)
Dec 2014
$11.00M(-98.4%)
-$259.00M(-475.4%)
$11.00M(-85.3%)
Sep 2014
-
$69.00M(0.0%)
$75.00M(-78.6%)
Jun 2014
-
$69.00M(-47.7%)
$350.00M(-34.7%)
Mar 2014
-
$132.00M(-167.7%)
$536.00M(-23.0%)
Dec 2013
$696.00M(-49.4%)
-$195.00M(-156.7%)
$696.00M(-42.3%)
Sep 2013
-
$344.00M(+34.9%)
$1.21B(-12.2%)
Jun 2013
-
$255.00M(-12.7%)
$1.37B(+9.0%)
Mar 2013
-
$292.00M(-7.6%)
$1.26B(-8.4%)
Dec 2012
$1.38B(-41.0%)
$316.00M(-38.2%)
$1.38B(-14.1%)
Sep 2012
-
$511.00M(+262.4%)
$1.60B(-9.8%)
Jun 2012
-
$141.00M(-65.4%)
$1.77B(-25.1%)
Mar 2012
-
$408.00M(-24.6%)
$2.37B(+1.5%)
Dec 2011
$2.33B(-19.4%)
$541.00M(-20.9%)
$2.33B(-4.5%)
Sep 2011
-
$684.00M(-6.9%)
$2.44B(-0.8%)
Jun 2011
-
$735.00M(+97.1%)
$2.46B(-2.6%)
Mar 2011
-
$373.00M(-42.7%)
$2.53B(-12.7%)
DateAnnualQuarterlyTTM
Dec 2010
$2.90B(-11.2%)
$651.00M(-7.5%)
$2.90B(+1.7%)
Sep 2010
-
$704.00M(-12.1%)
$2.85B(-6.8%)
Jun 2010
-
$801.00M(+8.2%)
$3.05B(-2.9%)
Mar 2010
-
$740.00M(+22.9%)
$3.14B(-3.6%)
Dec 2009
$3.26B(+27.9%)
$602.00M(-33.9%)
$3.26B(+1.4%)
Sep 2009
-
$911.00M(+2.2%)
$3.22B(+6.8%)
Jun 2009
-
$891.00M(+3.7%)
$3.01B(+8.7%)
Mar 2009
-
$859.00M(+54.2%)
$2.77B(+8.7%)
Dec 2008
$2.55B(+8.3%)
$557.00M(-21.0%)
$2.55B(-0.2%)
Sep 2008
-
$705.00M(+8.3%)
$2.56B(+7.0%)
Jun 2008
-
$651.00M(+2.0%)
$2.39B(+4.2%)
Mar 2008
-
$638.00M(+13.5%)
$2.29B(-2.8%)
Dec 2007
$2.36B(-5.0%)
$562.00M(+4.7%)
$2.36B(-3.9%)
Sep 2007
-
$537.00M(-3.1%)
$2.45B(-2.3%)
Jun 2007
-
$554.00M(-21.2%)
$2.51B(-2.1%)
Mar 2007
-
$703.00M(+6.8%)
$2.56B(+3.3%)
Dec 2006
$2.48B(+27.6%)
$658.00M(+10.6%)
$2.48B(+8.6%)
Sep 2006
-
$595.00M(-2.0%)
$2.28B(+3.7%)
Jun 2006
-
$607.00M(-2.1%)
$2.20B(+3.9%)
Mar 2006
-
$620.00M(+34.2%)
$2.12B(+9.1%)
Dec 2005
$1.94B(+67.4%)
$462.00M(-9.9%)
$1.94B(+5.2%)
Sep 2005
-
$513.00M(-2.3%)
$1.85B(+14.4%)
Jun 2005
-
$525.00M(+18.5%)
$1.61B(+22.4%)
Mar 2005
-
$443.00M(+21.0%)
$1.32B(+13.6%)
Dec 2004
$1.16B(+12.4%)
$366.00M(+30.7%)
$1.16B(+27.4%)
Sep 2004
-
$280.00M(+21.7%)
$911.00M(-2.8%)
Jun 2004
-
$230.00M(-19.3%)
$937.30M(-2.5%)
Mar 2004
-
$285.00M(+145.7%)
$961.41M(-6.9%)
Dec 2003
$1.03B(-12.2%)
$116.00M(-62.1%)
$1.03B(-14.6%)
Sep 2003
-
$306.30M(+20.5%)
$1.21B(+5.8%)
Jun 2003
-
$254.11M(-28.7%)
$1.14B(-2.9%)
Mar 2003
-
$356.59M(+21.7%)
$1.18B(+0.0%)
Dec 2002
$1.18B(+2.1%)
$292.95M(+22.0%)
$1.18B(+0.3%)
Sep 2002
-
$240.05M(-16.6%)
$1.17B(-3.3%)
Jun 2002
-
$288.00M(-19.1%)
$1.21B(+1.1%)
Mar 2002
-
$356.00M(+23.2%)
$1.20B(+4.2%)
Dec 2001
$1.15B(-11.3%)
$289.00M(+3.2%)
$1.15B(-12.4%)
Sep 2001
-
$280.00M(+1.8%)
$1.31B(+0.6%)
Jun 2001
-
$275.00M(-10.7%)
$1.31B(-2.3%)
Mar 2001
-
$308.00M(-31.9%)
$1.34B(+3.0%)
Dec 2000
$1.30B(+24.0%)
$451.99M(+65.9%)
$1.30B(+31.3%)
Sep 2000
-
$272.37M(-10.8%)
$989.45M(-1.0%)
Jun 2000
-
$305.42M(+13.3%)
$999.07M(-0.7%)
Mar 2000
-
$269.65M(+89.9%)
$1.01B(+36.6%)
Dec 1999
$1.05B(+16.1%)
$142.00M(-49.6%)
$736.00M(+23.9%)
Sep 1999
-
$282.00M(-9.6%)
$594.00M(+90.4%)
Jun 1999
-
$312.00M(-1.9%)
$312.00M(-1.9%)
Dec 1998
$903.00M(+58.3%)
-
-
Jun 1998
-
$318.00M(+147.7%)
$318.00M(+147.7%)
Dec 1997
$570.32M(+4.1%)
-
-
Dec 1996
$548.00M(+32.3%)
-
-
Dec 1995
$414.12M(+26.1%)
-
-
Jun 1995
-
$128.40M
$128.40M
Dec 1994
$328.31M(+17.4%)
-
-
Dec 1993
$279.57M(+1743.3%)
-
-
Dec 1992
$15.17M(-95.1%)
-
-
Dec 1991
$312.49M(+35.0%)
-
-
Dec 1990
$231.47M
-
-

FAQ

  • What is AstraZeneca annual income tax?
  • What is the all time high annual income tax for AstraZeneca?
  • What is AstraZeneca annual income tax year-on-year change?
  • What is AstraZeneca quarterly income tax?
  • What is the all time high quarterly income tax for AstraZeneca?
  • What is AstraZeneca quarterly income tax year-on-year change?
  • What is AstraZeneca TTM income tax?
  • What is the all time high TTM income tax for AstraZeneca?
  • What is AstraZeneca TTM income tax year-on-year change?

What is AstraZeneca annual income tax?

The current annual income tax of AZN is $1.65B

What is the all time high annual income tax for AstraZeneca?

AstraZeneca all-time high annual income tax is $3.26B

What is AstraZeneca annual income tax year-on-year change?

Over the past year, AZN annual income tax has changed by +$712.00M (+75.91%)

What is AstraZeneca quarterly income tax?

The current quarterly income tax of AZN is $481.00M

What is the all time high quarterly income tax for AstraZeneca?

AstraZeneca all-time high quarterly income tax is $911.00M

What is AstraZeneca quarterly income tax year-on-year change?

Over the past year, AZN quarterly income tax has changed by -$139.00M (-22.42%)

What is AstraZeneca TTM income tax?

The current TTM income tax of AZN is $1.51B

What is the all time high TTM income tax for AstraZeneca?

AstraZeneca all-time high TTM income tax is $3.26B

What is AstraZeneca TTM income tax year-on-year change?

Over the past year, AZN TTM income tax has changed by +$411.00M (+37.36%)
On this page